Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2005
11/17/2005US20050255085 Prevention of recurrence and metastasis of cancer
11/17/2005US20050255084 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
11/17/2005DE10393431T5 Mikroarrays mit mehreren Oligonukleotiden in einzelnen Array Features Microarrays with multiple oligonucleotides in each array features
11/17/2005DE102004021822B3 Verfahren und Anordnung zur DNA-Amplifikation mittels PCR unter Einsatz von Trockenreagenzien Method and system for DNA amplification by PCR using dry reagents
11/17/2005DE102004010828B3 Verfahren und Mittel zum thermischen Konditionieren einer Zelle Method and means for thermal conditioning a cell
11/17/2005DE102004010547A1 Oligoribonukleotide zur Behandlung von irritativen und/oder entzündlichen Hauterscheinungen durch RNA-Interferenz Oligoribonucleotides for the treatment of irritative and / or inflammatory skin lesions by RNA interference
11/17/2005DE10050942B4 Verfahren zum Nachweis von Cytosin-Methylierungen A method for the detection of cytosine methylations
11/17/2005CA2569085A1 Polynucleotides for the detection of escherichia coli
11/17/2005CA2569083A1 Detecting disease association with aberrant glycogen synthase kinase 3.beta. expression
11/17/2005CA2566423A1 Novel hiv-based recombinant viral clones and use thereof in analytical methods
11/17/2005CA2566418A1 Polynucleotides for the detection of staphylococcus aureus
11/17/2005CA2566344A1 Mutant pneumolysin proteins
11/17/2005CA2566189A1 Mutant saccharomyces cerevisiae strain utilizing xylose for ethanol production
11/17/2005CA2566041A1 T-type calcium channel splice variant compositions and methods
11/17/2005CA2565572A1 A microfluidic device and methods for processing polynucleotide-containing samples
11/17/2005CA2565509A1 Recombinant virus vector for gene introduction in lymphocyte
11/17/2005CA2565466A1 Cell preparation
11/17/2005CA2564769A1 Cellular permissivity factor for viruses, and uses thereof
11/17/2005CA2564503A1 Methods and compositions for reducing viral genome amounts in a target cell
11/17/2005CA2564202A1 Ammonium/ammonia transporter
11/17/2005CA2564039A1 Methods for assembling multiple expression constructs
11/17/2005CA2563521A1 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/17/2005CA2563329A1 Medical device with coating for capturing genetically-altered cells and methods of using same
11/17/2005CA2563206A1 Novel herbicide resistance genes
11/17/2005CA2562552A1 Hybrid recombinases for genome manipulation
11/17/2005CA2560865A1 Cancer associated antigens
11/17/2005CA2560264A1 Gm1 promoter and use thereof
11/17/2005CA2547933A1 Secreted insecticidal protein and gene compositions from bacillus thuringiensis and uses therefor
11/17/2005CA2504960A1 Method for controlling weeds
11/16/2005EP1596196A2 Protein interaction chip
11/16/2005EP1595960A1 DNA detection via complex of reassociated strings
11/16/2005EP1595959A1 Method for enhancing efficacy of preparation of monoclonal antibody
11/16/2005EP1595955A1 Beta 1,3-n-acetyl-d-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same
11/16/2005EP1595954A1 Human papilloma virus inhibition by antisense oligonucleotides
11/16/2005EP1595952A1 Method of estimating antitumor effect of histone deacetylase inhibitor
11/16/2005EP1595951A1 Diagnosis and treatment of diseases using peptides which are bound by specific anti-anti-t-cell receptor vbeta antibodies
11/16/2005EP1595949A1 Method of degrading plastic and process for producing useful substance using the same
11/16/2005EP1595948A2 Carriers having biological substance
11/16/2005EP1595947A1 MN gene and protein
11/16/2005EP1595946A2 STE20-related protein kinases
11/16/2005EP1595941A2 Microinjectiuon device and microinjection method
11/16/2005EP1595890A2 Synthetic peptide inhibitors of HIV transmission
11/16/2005EP1595447A1 Transgenic animal having fatty acid desaturase and method of producing the same
11/16/2005EP1594988A2 Method of diagnosis of type 2 diabetes and early onset thereof
11/16/2005EP1594981A2 Double ended sequencing
11/16/2005EP1594980A2 Bead emulsion nucleic acid amplification
11/16/2005EP1594977A2 Reversible attachment of a membrane active polymer to a polynucleotide
11/16/2005EP1594973A1 Transposon-based targeting system
11/16/2005EP1594972A2 Transposon-based targeting system
11/16/2005EP1594971A2 Transposon-based targeting system
11/16/2005EP1594970A1 Recombinant mva and method for generation thereof
11/16/2005EP1594969A2 Active immunization to generate antibodies to soluble a-beta
11/16/2005EP1594967A1 MICROBIAL PRODUCTION OF C sb O /sb Q10
11/16/2005EP1594966A2 Delta-endotoxin genes and methods for their use
11/16/2005EP1594965A2 Fusion proteins of interferon alpha muteins with improved properties
11/16/2005EP1594964A2 Oligonucleotides which inhibit the expression of the ob-rgrp protein and method for detection of compounds modifying the interaction between the proteins of the ob-rgrp family and the leptin receptor
11/16/2005EP1594963A2 Proteases
11/16/2005EP1594961A2 Glyphosate resistant class i 5-enolpyruvylshikimate-3-phosphate synthase (epsps)
11/16/2005EP1594960A2 Human cyclooxygenase-3 and uses thereof
11/16/2005EP1594956A2 System for expression of genes in plants
11/16/2005EP1594955A2 An expression cassette and vector for transient or stable expression of exogenous molecules
11/16/2005EP1594954A2 Directed genetic modifications of human stem cells
11/16/2005EP1594950A2 Method for preparing single-stranded dna libraries
11/16/2005EP1594900A2 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers
11/16/2005EP1594896A1 Modified soluble t cell receptor
11/16/2005EP1594892A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
11/16/2005EP1594889A2 Nell peptide expression systems and bone formation activity of nell peptide
11/16/2005EP1594883A2 Covalent modification of rna for in vitro and in vivo delivery
11/16/2005EP1594549A2 Hypoxia inducible vegf plasmid for ischemic disease
11/16/2005EP1594537A1 Vaccination or immunization using a prime-boost regimen against brsv, bhv-1, bvdv, bpi-3
11/16/2005EP1594535A2 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins
11/16/2005EP1594527A2 Vegf-b and pdgf modulation of stem cells
11/16/2005EP1594446A2 CALCIUM-SENSING RECEPTOR 2 (CaR2) AND METHODS FOR USING
11/16/2005EP1594436A2 Polymer conjugates of mutated neublastin
11/16/2005EP1594435A2 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein
11/16/2005EP1594358A1 Animal model for inflammatory bowel disease
11/16/2005EP1573001A4 Yeast treatment
11/16/2005EP1531664A4 Genes encoding proteins with pesticidal activity
11/16/2005EP1506223B1 Fusion protein of hiv regulatory/accessory proteins
11/16/2005EP1498129B1 Use of adenoviruses mutated in the va genes for cancer treatment
11/16/2005EP1497437A4 Lentiviral vector particles resistant to complement inactivation
11/16/2005EP1490768A4 Adaptive behavioral intrusion detection systems and methods
11/16/2005EP1487472A4 Stabilization of hypoxia inducible factor (hif) alpha
11/16/2005EP1463823A4 Methods of increasing endogenous erythropoietin (epo)
11/16/2005EP1436424A4 Differential tagging of polymers for high resolution linear analysis
11/16/2005EP1402072A4 Accurate and efficient quantification of dna sensitivity by real-time pcr
11/16/2005EP1399568B1 Method for producing recombinant trypsin
11/16/2005EP1392868A4 Method for the synthesis of dna sequences
11/16/2005EP1322786A4 Method of identifying putative antibiotic resistance genes
11/16/2005EP1319082B1 Expression vectors containing hybrid ubiquitin promoters
11/16/2005EP1315805B1 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures
11/16/2005EP1294927B1 Screening-method for modulators of methyltransferase-dependent chromosome stability
11/16/2005EP1213353B1 Peptide leukotriene receptor
11/16/2005EP1206550B1 Proteins derived from white spot syndrome virus and uses thereof
11/16/2005EP1153135B1 Methods for modulating the levels of organic sulfur compounds in plants
11/16/2005EP1109823B1 Modifications of the vegf receptor-2 protein and methods of use
11/16/2005EP1105537B1 Method for determining polynucleotide sequence variations
11/16/2005EP1082423B1 Cyclin e2 genes and proteins
11/16/2005EP1068328B1 Treatment and diagnosis of staphylococcal infections
11/16/2005EP1062235B1 A method for isolating and purifying soluble proteins and peptides from plant sources